In chemoresistant OC cells, TGF-β signaling is often impaired, particularly through the disruption of the suppressor of mothers against decapentaplegic 3 (SMAD3) phosphorylation, reducing its tumor-suppressive effects [15]. This evidence concerns the gene TGFB1 and neoplasm.